{"id":4371,"date":"2021-05-31T14:52:41","date_gmt":"2021-05-31T14:52:41","guid":{"rendered":"https:\/\/carlcon.com\/?p=4371"},"modified":"2021-05-31T14:52:43","modified_gmt":"2021-05-31T14:52:43","slug":"fmdq-lists-fidson-healthcare-maiden-commercial-paper-platform","status":"publish","type":"post","link":"https:\/\/carlcon.com\/old\/2021\/05\/31\/fmdq-lists-fidson-healthcare-maiden-commercial-paper-platform\/","title":{"rendered":"FMDQ lists Fidson Healthcare maiden Commercial paper  platform"},"content":{"rendered":"\n<p>FMDQ Securities Exchange Ltd., has approved the quotation of the Fidson Healthcare , N4.50 billion Series 1 Commercial Paper (CP) under its N10 billion CP issuance Programme.<br>FMDQ disclosed this in a statement in Lagos.<br>Fidson Healthcare is a leading pharmaceutical manufacturing company that is engaged in manufacturing and sale of pharmaceutical and healthcare products in Nigeria.<br>The statement noted that the issuance was approved by its Board Listings and Markets Committee&#8230;&#8230;&#8230;..TO CONTINUE READING CLICK ON<a href=\"https:\/\/thefreezonechannel.com\/fmdq-lists-fidson-healthcare-maiden-commercial-paper-platform\/\">https:\/\/thefreezonechannel.com\/fmdq-lists-fidson-healthcare-maiden-commercial-paper-platform\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FMDQ Securities Exchange Ltd., has approved the quotation of the Fidson Healthcare , N4.50 billion Series 1 Commercial Paper (CP) under its N10 billion CP issuance Programme.FMDQ disclosed this in a statement in Lagos.Fidson Healthcare is a leading pharmaceutical manufacturing company that is engaged in manufacturing and sale of pharmaceutical and healthcare products in Nigeria.The<\/p>\n","protected":false},"author":1,"featured_media":4372,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/posts\/4371"}],"collection":[{"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/comments?post=4371"}],"version-history":[{"count":1,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/posts\/4371\/revisions"}],"predecessor-version":[{"id":4373,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/posts\/4371\/revisions\/4373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/media\/4372"}],"wp:attachment":[{"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/media?parent=4371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/categories?post=4371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlcon.com\/old\/wp-json\/wp\/v2\/tags?post=4371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}